Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel therapies and solutions for neurological and oncological diseases with urgent unmet medical need. Besides of using Lumosa`s own technology platform in drug development, the company is also actively engaged in scientific licensing and co-development collaboration, building a pipeline from early to late-stage assets consisting of first-in-class and best-in-class drug products through leveraging the company’s broad global network and drug development competence.